257 related articles for article (PubMed ID: 25752815)
1. Signaling pathways in HPV-associated cancers and therapeutic implications.
Chen J
Rev Med Virol; 2015 Mar; 25 Suppl 1():24-53. PubMed ID: 25752815
[TBL] [Abstract][Full Text] [Related]
2. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
3. MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.
Luna AJ; Sterk RT; Griego-Fisher AM; Chung JY; Berggren KL; Bondu V; Barraza-Flores P; Cowan AT; Gan GN; Yilmaz E; Cho H; Kim JH; Hewitt SM; Bauman JE; Ozbun MA
PLoS Pathog; 2021 Jan; 17(1):e1009216. PubMed ID: 33481911
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
5. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
7. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
9. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
[TBL] [Abstract][Full Text] [Related]
10. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Cellular Metabolism by High-Risk Human Papillomaviruses.
Martínez-Ramírez I; Carrillo-García A; Contreras-Paredes A; Ortiz-Sánchez E; Cruz-Gregorio A; Lizano M
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932118
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.
Chakrabarti O; Krishna S
J Biosci; 2003 Apr; 28(3):337-48. PubMed ID: 12734411
[TBL] [Abstract][Full Text] [Related]
13. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
Kim MK; Kim HS; Kim SH; Oh JM; Han JY; Lim JM; Juhnn YS; Song YS
Biochem Pharmacol; 2010 Dec; 80(12):1930-5. PubMed ID: 20643111
[TBL] [Abstract][Full Text] [Related]
15. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
16. The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
Thomas M; Pim D; Banks L
Oncogene; 1999 Dec; 18(53):7690-700. PubMed ID: 10618709
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.
Duensing S; Münger K
Int J Cancer; 2004 Mar; 109(2):157-62. PubMed ID: 14750163
[TBL] [Abstract][Full Text] [Related]
18. Novel Functions of the Human Papillomavirus E6 Oncoproteins.
Wallace NA; Galloway DA
Annu Rev Virol; 2015 Nov; 2(1):403-23. PubMed ID: 26958922
[TBL] [Abstract][Full Text] [Related]
19. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
